These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

587 related items for PubMed ID: 16046590

  • 1. Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease.
    Meyer C, McGrath BP, Teede HJ.
    J Clin Endocrinol Metab; 2005 Oct; 90(10):5711-6. PubMed ID: 16046590
    [Abstract] [Full Text] [Related]

  • 2. Vascular dysfunction and metabolic parameters in polycystic ovary syndrome.
    Meyer C, McGrath BP, Cameron J, Kotsopoulos D, Teede HJ.
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4630-5. PubMed ID: 15870132
    [Abstract] [Full Text] [Related]

  • 3. Flow-mediated dilatation in overweight and obese women with polycystic ovary syndrome.
    Brinkworth GD, Noakes M, Moran LJ, Norman R, Clifton PM.
    BJOG; 2006 Nov; 113(11):1308-14. PubMed ID: 17059392
    [Abstract] [Full Text] [Related]

  • 4. Central arterial stiffness and diastolic dysfunction are associated with insulin resistance and abdominal obesity in young women but polycystic ovary syndrome does not confer additional risk.
    Rees E, Coulson R, Dunstan F, Evans WD, Blundell HL, Luzio SD, Dunseath G, Halcox JP, Fraser AG, Rees DA.
    Hum Reprod; 2014 Sep; 29(9):2041-9. PubMed ID: 25035436
    [Abstract] [Full Text] [Related]

  • 5. Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype.
    Armeni E, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.
    J Hypertens; 2013 Oct; 31(10):1998-2004. PubMed ID: 24107731
    [Abstract] [Full Text] [Related]

  • 6. Circulating levels of obestatin and copeptin in obese and nonobese women with polycystic ovary syndrome.
    Taskin MI, Bulbul E, Adali E, Hismiogulları AA, Inceboz U.
    Eur J Obstet Gynecol Reprod Biol; 2015 Jun; 189():19-23. PubMed ID: 25837320
    [Abstract] [Full Text] [Related]

  • 7. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome.
    Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ.
    Clin Sci (Lond); 2009 May; 116(10):761-70. PubMed ID: 18851710
    [Abstract] [Full Text] [Related]

  • 8. Blood pressure regulation and resting heart rate abnormalities in adolescent girls with polycystic ovary syndrome.
    Zachurzok-Buczynska A, Szydlowski L, Gawlik A, Wilk K, Malecka-Tendera E.
    Fertil Steril; 2011 Dec; 96(6):1519-25. PubMed ID: 22032814
    [Abstract] [Full Text] [Related]

  • 9. Troglitazone therapy improves endothelial function to near normal levels in women with polycystic ovary syndrome.
    Paradisi G, Steinberg HO, Shepard MK, Hook G, Baron AD.
    J Clin Endocrinol Metab; 2003 Feb; 88(2):576-80. PubMed ID: 12574183
    [Abstract] [Full Text] [Related]

  • 10. Visceral fat is associated with cardiovascular risk in women with polycystic ovary syndrome.
    Cascella T, Palomba S, De Sio I, Manguso F, Giallauria F, De Simone B, Tafuri D, Lombardi G, Colao A, Orio F.
    Hum Reprod; 2008 Jan; 23(1):153-9. PubMed ID: 18024952
    [Abstract] [Full Text] [Related]

  • 11. Endothelial dysfunction in PCOS: role of obesity and adipose hormones.
    Carmina E, Orio F, Palomba S, Longo RA, Cascella T, Colao A, Lombardi G, Rini GB, Lobo RA.
    Am J Med; 2006 Apr; 119(4):356.e1-6. PubMed ID: 16564785
    [Abstract] [Full Text] [Related]

  • 12. High-sensitivity C-reactive protein (hs-CRP) levels and its relationship with components of polycystic ovary syndrome in Indian adolescent women with polycystic ovary syndrome (PCOS).
    Ganie MA, Hassan S, Nisar S, Shamas N, Rashid A, Ahmed I, Douhat S, Mudassar S, Jan VM, Rashid F.
    Gynecol Endocrinol; 2014 Nov; 30(11):781-4. PubMed ID: 25137507
    [Abstract] [Full Text] [Related]

  • 13. Severe endothelial dysfunction in young women with polycystic ovary syndrome is only partially explained by known cardiovascular risk factors.
    Sorensen MB, Franks S, Robertson C, Pennell DJ, Collins P.
    Clin Endocrinol (Oxf); 2006 Nov; 65(5):655-9. PubMed ID: 17054469
    [Abstract] [Full Text] [Related]

  • 14. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ, Morrison JA, Friedman LA, Goldenberg N, Stroop DM, Wang P.
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [Abstract] [Full Text] [Related]

  • 15. Predictors of endothelial dysfunction in young women with polycystic ovary syndrome.
    Kravariti M, Naka KK, Kalantaridou SN, Kazakos N, Katsouras CS, Makrigiannakis A, Paraskevaidis EA, Chrousos GP, Tsatsoulis A, Michalis LK.
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5088-95. PubMed ID: 15985492
    [Abstract] [Full Text] [Related]

  • 16. The effect of a hypocaloric diet with and without exercise training on body composition, cardiometabolic risk profile, and reproductive function in overweight and obese women with polycystic ovary syndrome.
    Thomson RL, Buckley JD, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    J Clin Endocrinol Metab; 2008 Sep; 93(9):3373-80. PubMed ID: 18583464
    [Abstract] [Full Text] [Related]

  • 17. Comparison of aerobic exercise capacity and muscle strength in overweight women with and without polycystic ovary syndrome.
    Thomson RL, Buckley JD, Moran LJ, Noakes M, Clifton PM, Norman RJ, Brinkworth GD.
    BJOG; 2009 Aug; 116(9):1242-50. PubMed ID: 19438498
    [Abstract] [Full Text] [Related]

  • 18. Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity--but not a PCOS-associated phenomenon.
    Ketel IJ, Stehouwer CD, Henry RM, Serné EH, Hompes P, Homburg R, Smulders YM, Lambalk CB.
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4566-75. PubMed ID: 20660051
    [Abstract] [Full Text] [Related]

  • 19. Effects of exercise on insulin resistance and body composition in overweight and obese women with and without polycystic ovary syndrome.
    Hutchison SK, Stepto NK, Harrison CL, Moran LJ, Strauss BJ, Teede HJ.
    J Clin Endocrinol Metab; 2011 Jan; 96(1):E48-56. PubMed ID: 20926534
    [Abstract] [Full Text] [Related]

  • 20. C-reactive protein before and after weight loss in overweight women with and without polycystic ovary syndrome.
    Moran LJ, Noakes M, Clifton PM, Wittert GA, Belobrajdic DP, Norman RJ.
    J Clin Endocrinol Metab; 2007 Aug; 92(8):2944-51. PubMed ID: 17504892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.